- Production involves the use of mice. These mice are used to produce both antibodies and tumour cells. The production of tumour cells involves deliberately inducing cancer in mice. Despite specific guidelines drawn up to minimise any suffering, some people still have reservations about using animals in this way.
- To eliminate the need for humanisation of the antibody, transgenic mice can be used. In this case, a human gene is placed in the mice to that they can produce human antibodies rather than mouse antibodies. This raises the whole debate surrounding the ethics of genetic engineering.
- Monoclonal antibodies have been used successfully to treat a number of diseases, including cancer and Diabetes, saving many lives. There have also been some deaths associated with their use in the treatment of multiple sclerosis.
- Testing for the safety of new drugs presents certain dangers. In march 2006, six healthy volunteers took part in the trial of new monoclonal antibody (TGN1412) in London. Within minutes they suffered multiple organ failure, probably as a result of T cells overproducing chemicals that stimulate an immune response or attacking the body tissues. All the volunteers survived, but it raises issues about the conduct of drug trials.
how do monoclonal antibodies help controlling plant disease?
Monoclonal-- Genetically engineered antibodies specific for one antigen.
monoclonal antibodies
Monoclonal antibodies are highly specific, targeting a single antigen, while polyclonal antibodies can target multiple antigens. Monoclonal antibodies are produced from a single clone of cells, resulting in uniformity, while polyclonal antibodies are produced from multiple clones of cells, leading to variability.
Monoclonal antibodies are commonly used to fight a large number of diseases including cancer. The monoclonal antibodies fight the disease by targeting a certain antigen and recruiting the body's natural immune system to destroy the antigen-infected cells.
yes
Monoclonal Antibodies
To kill things
Fully human monoclonal antibodies are derived entirely from human sources, making them less likely to cause immune reactions. They are generally more effective and have a lower risk of side effects compared to humanized monoclonal antibodies, which contain some non-human components. Fully human monoclonal antibodies are often preferred for medical treatments due to their higher specificity and reduced risk of adverse reactions.
No they can not
malkat singh
Monoclonal antibodies are created by fusing a specific type of immune cell, called a B cell, with a cancer cell to form a hybrid cell called a hybridoma. This hybridoma cell can then produce large quantities of identical antibodies that target a specific antigen. These monoclonal antibodies can be used for various medical purposes, such as diagnosing and treating diseases.